1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Kronox Lab Sciences Limited

Kronox Lab Sciences Limited

189.26
INR
-7.88
(-4.00%)
7.77EPS
19.30P/E
5.56BMarket Cap
Kronox Lab Sciences Limited
NSE:KRONOX
(National Stock Exchange of India)

Recent

price

189.26

P/E

ratio

19.30

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
2026
TTM
INR
16.83
22.17
25.76
24.22
27
27.28
28.64
Revenue per Share
2.62
3.67
4.48
5.75
6.86
7.45
7.77
Basic EPS, GAAP
2.6
1.41
3.03
1.39
7.44
5.55
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.5
0.5
- -
Dividend per Share
7.23
10.88
12.04
17.87
24.28
31.3
- -
Book Value per Share
7.23
10.88
12.04
17.87
24.28
31.3
- -
Tangible Book Value per Share
37
37
37
37
37
37
37
Basic Weighted Avg Shares
625
822
956
899
1,002
1,012
1,053
Sales/Revenue/Turnover
20.8
21.78
21.45
30.46
32.13
32.35
31.42
Operating Margin (%)
20
20
15
13
14
20
21
Depreciation Expense
97
136
166
214
255
277
286
Net Income, GAAP
26.4
25.76
25.58
25.37
25.69
25.85
25.9
Effective Tax Rate (%)
15.58
16.57
17.39
23.76
25.42
27.33
27.13
Profit Margin (%)
183
304
253
389
546
685
- -
Working Capital
27
22
- -
- -
- -
10
- -
LT Debt
268
404
447
663
901
1,161
- -
Total Equity
- -
35.85
34.97
36.79
30.53
23.22
- -
Return on Invested Capital (%)
- -
37.57
37.76
38.48
32.56
26.7
- -
Return on Capital (%)
- -
40.58
39.08
38.48
32.56
26.82
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
6
- -
LT Borrowings
- -
10
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
5,185
3,600
5,564

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
788
- -
Cash, Cash Equivalents & STI
- -
487
- -
Accounts Receivable, Net
- -
212
- -
Inventories
- -
84
- -
Total Current Liabilities
- -
104
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
6
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
34.88%
28.88%
Free Cash Flow
- -
85.21%
-25.4%
Net Income, GAAP
- -
23.67%
8.61%
Sales/Revenue/Turnover
- -
10.89%
1.02%
Total Cash Common Dividend
- -
- -
0.05%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
252
249
240
261
1,002
2026
243
255
253
261
1,012
2027
284
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.67
1.76
1.77
1.7
6.86
2026
1.7
1.82
1.79
2.16
7.45
2027
2
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.5
2026
- -
- -
- -
- -
0.5
2027
- -
- -
- -
- -
- -
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
Dow Inc. (NYSE:DOW)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Business
Kronox Lab Sciences Ltd. specializes in the production and global distribution of high-purity fine and inorganic chemicals, along with various phosphates and metallic compounds. The company offers a comprehensive range of bulk reagents, including ACS, LR, AR, and GR grades, designed for diverse applications. Its bulk ingredients cater to sectors such as oral hygiene, pharmacopoeia, food and nutraceuticals, personal care, cosmetics, and veterinary pharmaceuticals. Additionally, Kronox Lab Sciences provides an array of specialty chemicals, featuring items like tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and its derivatives, ultra-high purity substances, custom formulations, and specialty anhydrous compounds. Established in 2008, the company operates from its base in Vadodara, India, and successfully completed its Initial Public Offering in June 2024, listing on the BSE and NSE.